Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7238 p302
1 March 2003

This page
Reprint
Photocopy

   

PDF* 90K

Letters

  OFT report
  Corporate pharmacy
  Supermarket pharmacy
  CPD
  Chloroform water
  Antipsychotics
  Advertising
  Pharmacist prescribing
  Dentistry
  APPG
  The Register
  Dispensing
  The Profession
  Leadership
  The Council
  The Society


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Dentistry

Use of diazepam in dental emergencies

From Ms S. M. S. Wagle, MRPharmS

Kevin Smith (PJ, 15 February, p228) seeks information on the use of diazepam in emergencies that a dental surgeon might face.

NHS Dental Surgeons are issued with the Dental Practitioners' Formulary (DPF) every two years; the most recent one was published in October 2002. The DPF includes a section on medical emergencies in dental practice, together with a list of medicines that are likely to be needed in such emergencies.

For epileptic seizures in the dental surgery, in addition to general advice on ensuring that the patient does not come to any harm during the seizure, the DPF advises that "medication should only be given if convulsive seizures are prolonged (convulsive movements lasting 5 minutes or longer) or repeated rapidly" and that "intravenous administration of diazepam 10mg is often effective but should be used with caution because of the risk of respiratory depression" (BNF 44, p240).

The BNF states that absorption of diazepam from intramuscular injection is too slow for treatment of status epilepticus. The rectal solution of diazepam is absorbed rapidly but, as Mr Smith points out, there is considerable anxiety over the emergency use of rectal preparations in dentistry as well as in general medicine.

A number of emergencies call for the administration of drugs by the intravenous route: these include glucose intravenous infusion for severe hypoglycaemia unresponsive to glucagon, hydrocortisone injection for severe asthma unresponsive to a beta2 agonist, and chlorphenamine for secondary treatment of anaphylaxis.

The Dental Formulary Subcommittee has taken considerable advice on the management of medical emergencies in the dental surgery. The advice is constantly validated by appropriate experts and it is applicable throughout the United Kingdom. Any local policies would do well to take into account the DPF's advice.

Shama Wagle
Assistant Editor,
BNF/DPF

Send your letter to The Editor

Previous Topic (Pharmacist prescribing)
Next Topic (APPG)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal